FASEB J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nishimura, H.
Right arrow Articles by Yoshikai, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nishimura, H.
Right arrow Articles by Yoshikai, Y.
(The FASEB Journal. 2005;19:19-28.)
© 2005 FASEB

A novel autoregulatory mechanism for transcriptional activation of the IL-15 gene by a nonsecretable isoform of IL-15 generated by alternative splicing

Hitoshi Nishimura*,1, Atsushi Fujimoto{dagger}, Naoyuki Tamura*, Toshiki Yajima*, Worawidh Wajjwalku{dagger} and Yasunobu Yoshikai*

* Division of Host Defense, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan; and
{dagger} Laboratory of Host Defense & Germfree Life, Research Institute for Disease Mechanism and Control, Nagoya University School of Medicine, Nagoya, Japan

1Correspondence: Division of Host Defense, Medical Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan. E-mail: nishihit{at}bioreg.kyushu-u.ac.jp

There are several isoforms of interleukin (IL) -15 generated by alternating splicing. We reported previously that alternative IL-15 transgenic (Tg) mice expressing an IL-15 cDNA isoform encoding nonsecretable IL-15 protein had an impaired ability to produce IL-15. In this study, we found that expression of endogenous IL-15 mRNA but not tumor necrosis factor {alpha} mRNA was severely impaired in response to lipopolysaccharide, not only in macrophages from alternative IL-15 Tg mice but also in RAW264.7 cells that had been transfected with alternative IL-15 together with IL-15 receptor {alpha} (IL-15R{alpha}). IL-15 promoter activity was suppressed in the transfected cells. Although nuclear factor-{kappa}B activation was not impaired, the binding activity of nuclear extracts to the interferon-stimulated response element of the IL-15 promoter region was reduced in RAW264.7 cells, which had been cotransfected with alternative IL-15 and IL-15R{alpha}. IL-15 was mainly colocalized with IL-15R{alpha} at the cytoplasmic membrane of RAW264.7 cells, which had been cotransfected with normal IL-15, whereas nonsecretable IL-15 was colocalized with IL-15R{alpha} in nucleus after cotransfection with alternative IL-15 and IL-15R{alpha}. These results suggest that nonsecretable IL-15 generated by alternative splicing suppresses further IL-15 gene transcription, implying a novel autocrine regulatory mechanism for cytokine gene expression by alternative splicing.


Key Words: cytokine • gene transcription • negative feedback




This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
E. H. Duitman, Z. Orinska, E. Bulanova, R. Paus, and S. Bulfone-Paus
How a Cytokine Is Chaperoned through the Secretory Pathway by Complexing with Its Own Receptor: Lessons from Interleukin-15 (IL-15)/IL-15 Receptor {alpha}
Mol. Cell. Biol., August 1, 2008; 28(15): 4851 - 4861.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
A. Franchi, J. Zaret, X. Zhang, S. Bocca, and S. Oehninger
Expression of immunomodulatory genes, their protein products and specific ligands/receptors during the window of implantation in the human endometrium
Mol. Hum. Reprod., July 1, 2008; 14(7): 413 - 421.
[Abstract] [Full Text] [PDF]


Home page
J ANIM SCIHome page
L. S. Quinn
Interleukin-15: A muscle-derived cytokine regulating fat-to-lean body composition
J Anim Sci, April 1, 2008; 86(14_suppl): E75 - E83.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
Y. Kagimoto, H. Yamada, T. Ishikawa, N. Maeda, F. Goshima, Y. Nishiyama, M. Furue, and Y. Yoshikai
A regulatory role of interleukin 15 in wound healing and mucosal infection in mice
J. Leukoc. Biol., January 1, 2008; 83(1): 165 - 172.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Bulanova, V. Budagian, E. Duitman, Z. Orinska, H. Krause, R. Ruckert, N. Reiling, and S. Bulfone-Paus
Soluble Interleukin (IL)-15R{alpha} Is Generated by Alternative Splicing or Proteolytic Cleavage and Forms Functional Complexes with IL-15
J. Biol. Chem., May 4, 2007; 282(18): 13167 - 13179.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. A. Stoklasek, K. S. Schluns, and L. Lefrancois
Combined IL-15/IL-15R{alpha} Immunotherapy Maximizes IL-15 Activity In Vivo
J. Immunol., November 1, 2006; 177(9): 6072 - 6080.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. Lorenzen, A. J. Dingley, Y. Jacques, and J. Grotzinger
The Structure of the Interleukin-15{alpha} Receptor and Its Implications for Ligand Binding
J. Biol. Chem., March 10, 2006; 281(10): 6642 - 6647.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
M. Roberts, X. Luo, and N. Chegini
Differential regulation of interleukins IL-13 and IL-15 by ovarian steroids, TNF-{alpha} and TGF-{beta} in human endometrial epithelial and stromal cells
Mol. Hum. Reprod., October 1, 2005; 11(10): 751 - 760.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by The Federation of American Societies for Experimental Biology.